13F-HR filed by PERCEPTIVE ADVISORS LLC
PERCEPTIVE ADVISORS LLC filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-14, with 97 holding rows worth $2,997,910,052.
- Accession
- 0001012975-23-000471
- Filer
- CIK 1224962
- Filed
- 2023-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2023
A holdings report, 97 entries on the cover page, a total value of $2,997,910,052 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,997,910,052 with VALUE read as dollars as filed, 13F file number 028-10438. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 27,692,917 | $336,745,870 | dollars as filed | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 10,088,385 | $220,229,445 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 3,814,691 | $146,445,987 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 3,965,978 | $142,299,291 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 2,463,451 | $113,244,842 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 3,074,542 | $90,729,734 | dollars as filed | |
| LIANBIO ADR | 53000N108 | COM | 57,558,451 | $85,762,091 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 1,619,425 | $81,910,517 | dollars as filed | |
| INHIBRX INC | 45720L107 | COM | 4,256,104 | $78,099,508 | dollars as filed | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 11,350,085 | $75,818,568 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 150,600 | $74,039,478 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 1,342,751 | $68,453,446 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 4,007,197 | $65,317,311 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 4,043,191 | $60,283,978 | dollars as filed | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 11,331,103 | $55,635,715 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 11,962,938 | $54,431,367 | dollars as filed | |
| LYRA THERAPEUTICS INC | 55234L105 | COM | 12,757,562 | $49,882,067 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 2,688,873 | $49,233,265 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 1,748,933 | $46,119,363 | dollars as filed | |
| Medtronic Plc | G5960L103 | COM | 587,000 | $45,997,320 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 3,819,456 | $44,611,246 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 895,641 | $42,077,214 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 3,491,500 | $40,431,570 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 1,827,901 | $38,934,291 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 1,263,732 | $37,583,389 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 1,321,795 | $36,587,286 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 1,520,416 | $35,152,017 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 481,649 | $33,662,449 | dollars as filed | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 996,306 | $32,648,948 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 1,920,658 | $31,921,336 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 1,517,467 | $31,092,899 | dollars as filed | |
| NAUTILUS BIOTECHNOLOGY INC | 63909J108 | COM | 9,111,151 | $28,791,237 | dollars as filed | |
| ACRIVON THERAPEUTICS INC | 004890109 | CMN | 3,007,858 | $28,755,122 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 2,418,968 | $27,237,580 | dollars as filed | |
| ADMA BIOLOGICS INC | 000899104 | COM | 6,984,319 | $25,003,862 | dollars as filed | |
| TREACE MED CONCEPTS INC | 89455T109 | COM | 1,834,060 | $24,044,527 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 1,296,416 | $23,037,312 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 2,309,470 | $22,517,333 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 182,720 | $22,149,318 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 672,042 | $21,236,527 | dollars as filed | |
| ORCHESTRA BIOMED HOLDINGS IN | 68572M106 | COMMON STOCK | 2,432,089 | $21,207,816 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 617,500 | $21,093,800 | dollars as filed | |
| VERRICA PHARMACEUTICALS INC | 92511W108 | COM | 5,038,983 | $19,576,448 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 751,820 | $19,554,838 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 124,637 | $18,201,987 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 159,242 | $17,914,725 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 1,054,273 | $17,585,274 | dollars as filed | |
| RAYZEBIO INC | 75525N107 | COM | 776,805 | $17,245,071 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 1,132,491 | $17,236,513 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 1,943,097 | $16,341,445 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 2,189,462 | $16,333,387 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,011,205 | $15,511,885 | dollars as filed | |
| ARTIVION INC | 228903100 | COM | 931,352 | $14,119,296 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 277,683 | $13,625,905 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 1,485,801 | $13,580,221 | dollars as filed | |
| TACTILE SYSTEMS TECHNOLOGY I | 87357P100 | COMMON STOCK | 707,159 | $9,935,584 | dollars as filed | |
| BIOMEA FUSION INC | 09077A106 | CMN | 716,441 | $9,858,228 | dollars as filed | |
| ATHIRA PHARMA INC | 04746L104 | COM | 4,797,278 | $9,690,501 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 218,178 | $9,654,377 | dollars as filed | |
| ZYMEWORKS INC | 98985Y108 | COM | 1,446,123 | $9,168,420 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 3,495,933 | $8,809,751 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 380,828 | $8,730,482 | dollars as filed | |
| CAREMAX INC | 14171W103 | COM | 3,823,557 | $8,105,940 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 165,615 | $7,990,924 | dollars as filed | |
| OUTSET MEDICAL INC | 690145107 | COM | 661,977 | $7,202,310 | dollars as filed | |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 2,751,395 | $7,153,627 | dollars as filed | |
| LANDOS BIOPHARMA INC | 515069201 | COMMON | 1,486,991 | $5,769,525 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 800,000 | $5,460,000 | dollars as filed | call |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 1,075,000 | $5,407,250 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 360,000 | $4,957,200 | dollars as filed | |
| NANOBIOTIX | 63009J107 | SPONSORED ADS | 555,066 | $4,856,828 | dollars as filed | |
| AXOGEN INC | 05463X106 | COM | 875,898 | $4,379,490 | dollars as filed | |
| ENVVENO MEDICAL CORPORATION | 29415J106 | COM | 781,615 | $4,212,905 | dollars as filed | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 3,545,454 | $3,864,545 | dollars as filed | |
| NOVAVAX INC | 670002401 | COM NEW | 1,300,000 | $3,772,520 | dollars as filed | put |
| SOMALOGIC INC | 83444K105 | COM | 1,500,000 | $3,585,000 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 400,000 | $3,576,000 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 100,000 | $3,130,000 | dollars as filed | call |
| POINT BIOPHARMA GLOBAL INC | 730541109 | COM | 800,000 | $2,630,000 | dollars as filed | put |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 300,000 | $2,622,500 | dollars as filed | put |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 750,000 | $2,512,500 | dollars as filed | put |
| KRONOS BIO INC | 50107A104 | COM | 1,752,745 | $2,278,568 | dollars as filed | |
| FORTE BIOSCIENCES INC | 34962G109 | COM | 3,265,359 | $2,161,667 | dollars as filed | |
| ACELYRIN INC | 00445A100 | COM | 200,000 | $2,034,000 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 400,000 | $1,620,000 | dollars as filed | call |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 500,000 | $1,450,000 | dollars as filed | put |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 81,116 | $993,671 | dollars as filed | |
| VBI VACCINES INC | 91822J202 | Foreign Stock | 1,381,355 | $925,507 | dollars as filed | |
| SINGULAR GENOMICS SYSTEMS IN | 82933R100 | COM | 2,363,214 | $900,385 | dollars as filed | |
| Veru Inc | 92536C103 | Common Stock | 1,089,878 | $783,622 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 300,000 | $240,000 | dollars as filed | call |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 100,000 | $72,500 | dollars as filed | put |
| CYPHERPUNK TECHNOLOGIES INC | 52187K200 | COM NEW | 44,971 | $62,059 | dollars as filed | |
| MOTUS GI HLDGS INC | 62014P405 | COM | 90,027 | $40,512 | dollars as filed | |
| CAREMAX INC | 14171W111 | *W EXP 06/08/202 | 60,000 | $11,250 | dollars as filed | |
| EQRX INC | 26886C115 | *W EXP 12/17/202 | 250,000 | $10,000 | dollars as filed | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 166,666 | $6,667 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001012975-23-000471 | this filing | 2023-11-14 | acceptance time not in the bulk data set |